HALEON Stock Overview
Engages in the research and development, manufacture, marketing, and sale of consumer healthcare products in Pakistan, Africa, Australia, North America, Asia, the Middle East, and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Haleon Pakistan Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨882.45 |
| 52 Week High | PK₨832.52 |
| 52 Week Low | PK₨160.10 |
| Beta | 0.60 |
| 11 Month Change | 37.92% |
| 3 Month Change | 125.68% |
| 1 Year Change | 374.23% |
| 33 Year Change | 274.44% |
| 5 Year Change | 204.15% |
| Change since IPO | 1,256.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| HALEON | PK Personal Products | PK Market | |
|---|---|---|---|
| 7D | 11.7% | -2.0% | 2.1% |
| 1Y | 374.2% | -4.3% | 43.4% |
Return vs Industry: HALEON exceeded the PK Personal Products industry which returned -4.3% over the past year.
Return vs Market: HALEON exceeded the PK Market which returned 43.4% over the past year.
Price Volatility
| HALEON volatility | |
|---|---|
| HALEON Average Weekly Movement | 7.9% |
| Personal Products Industry Average Movement | 5.4% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in PK Market | 9.6% |
| 10% least volatile stocks in PK Market | 3.8% |
Stable Share Price: HALEON's share price has been volatile over the past 3 months compared to the PK market.
Volatility Over Time: HALEON's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of PK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 481 | Farhan Haroon | www.haleon.pk |
Haleon Pakistan Limited engages in the research and development, manufacture, marketing, and sale of consumer healthcare products in Pakistan, Africa, Australia, North America, Asia, the Middle East, and Europe. It offers oral health, pain relief, vitamins and mineral supplements, and respiratory health products. The company sells its products under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, Actified, T-Day, ENO, Herbactive, Hydrozole, Qalsium-D, and Voltral Emulgel brands.
Haleon Pakistan Limited Fundamentals Summary
| HALEON fundamental statistics | |
|---|---|
| Market cap | PK₨93.92b |
| Earnings (TTM) | PK₨3.57b |
| Revenue (TTM) | PK₨35.41b |
28.9x
P/E Ratio2.9x
P/S RatioIs HALEON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HALEON income statement (TTM) | |
|---|---|
| Revenue | PK₨35.41b |
| Cost of Revenue | PK₨24.27b |
| Gross Profit | PK₨11.14b |
| Other Expenses | PK₨7.57b |
| Earnings | PK₨3.57b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 30.51 |
| Gross Margin | 31.46% |
| Net Profit Margin | 10.08% |
| Debt/Equity Ratio | 3.1% |
How did HALEON perform over the long term?
See historical performance and comparison